Goldman Sachs Starts Abivax (ABVX) at Buy, 'screens well as a potential M&A target'

September 9, 2026 4:41 PM

(Updated - September 10, 2026 5:57 AM EDT)

Goldman Sachs analyst Rajan Sharma initiates coverage on Abivax (NASDAQ: ABVX) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found